Impact of restarting home neuropsychiatric medications on sedation outcomes in medical intensive care unit patients.

Published

Journal Article

This single-center, retrospective cohort study investigated the effects of timing of initiating home neuropsychiatric medications (NPMs) on sedation-related outcomes.Subjects included adult medical intensive care unit (MICU) patients who had an NPM on their admission medication list; intubated before or on arrival to the intensive care unit (ICU); and were on benzodiazepine-based sedation. The intervention assessed was the timing of the initiation of home NPMs: early (≤5days) vs. late (>5days) into the ICU stay.There were 56 and 53 patients in the early and late restart groups, respectively. Early cohort patients maintained a median daily RASS of -1.5, while late cohort patients had a median daily RASS of -2.0 (p=0.02). The effect was driven by the subgroup of patients on home anti-depressant therapy who were restarted early on these agents. The early restart group had a higher percentage of days with RASS scores within goal (p=0.01) and less delirium (p=0.02). Early restarting of home NPMs was associated with a non-significant decrease in ventilator days compared with late restarting (p=0.11).Restarting home NPMs was associated with lighter sedation levels and less delirium.

Full Text

Duke Authors

Cited Authors

  • La, MK; Thompson Bastin, ML; Gisewhite, JT; Johnson, CA; Flannery, AH

Published Date

  • February 2018

Published In

Volume / Issue

  • 43 /

Start / End Page

  • 102 - 107

PubMed ID

  • 28865338

Pubmed Central ID

  • 28865338

Electronic International Standard Serial Number (EISSN)

  • 1557-8615

International Standard Serial Number (ISSN)

  • 0883-9441

Digital Object Identifier (DOI)

  • 10.1016/j.jcrc.2017.07.046

Language

  • eng